InsiderClue
Stocks · Health care · Services-Medical Laboratories

Fulgent Genetics, Inc.

FLGT Clue Score31
United States Fiscal year ends December CIK 0001674930 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Paul Kim
5 Mar 2025
CFO and Treasurer
Buy
100,000
$15.96
$1.60M
Ming Hsieh
5 Mar 2019
President and CEO
Buy
8,739
$4.95
$43.24K
Ming Hsieh
13 Nov 2018
President and CEO
Buy
10,880
$3.59
$39.03K
Ming Hsieh
9 Nov 2018
President and CEO
Buy
10,000
$3.36
$33.61K
Ming Hsieh
30 Nov 2017
President and CEO
Buy indirect
1,000
$3.60
$3.60K
Ming Hsieh
30 Nov 2017
President and CEO
Buy indirect
1,000
$3.60
$3.60K
Ming Hsieh
21 Nov 2017
President and CEO
Buy
1,599
$3.13
$5.00K
Ming Hsieh
20 Nov 2017
President and CEO
Buy
7,259
$3.28
$23.81K
Ming Hsieh
17 Nov 2017
President and CEO
Buy
12,291
$3.16
$38.86K
Ming Hsieh
16 Nov 2017
President and CEO
Buy
1,905
$3.22
$6.14K
Ming Hsieh
15 Nov 2017
President and CEO
Buy
300
$3.28
$984.99
Ming Hsieh
14 Nov 2017
President and CEO
Buy
2,800
$3.35
$9.37K
Ming Hsieh
13 Nov 2017
President and CEO
Buy
7,704
$3.28
$25.27K
Ming Hsieh
10 Nov 2017
President and CEO
Buy
9,385
$3.35
$31.40K
Ming Hsieh
9 Nov 2017
President and CEO
Buy
11,520
$3.47
$40.03K
Ming Hsieh
15 Jun 2017
President and CEO
Buy
12,700
$5.35
$67.95K
Ming Hsieh
14 Jun 2017
President and CEO
Buy
7,300
$5.11
$37.28K
Ming Hsieh
13 Jun 2017
President and CEO
Buy
15,000
$5.01
$75.19K
Ming Hsieh
12 Jun 2017
President and CEO
Buy
15,000
$4.95
$74.21K
Show all 178 transactions →

What was left out

Form 4 filings counted 376
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 145
Transactions with no price 0
Shares from compensation/vesting 5,339,621
Sales filed before the plan box existed 84
History held since 4 Oct 2016